Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.